Zhao Wl

AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2

Y. Liang, Z. Chen, Jing-yi Shi, 2009, Leukemia.

Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy

D. Xiao, L. Wang, Z-X Shen, 2012, Cell Death and Disease.

The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis

F. Yang, A. Janin, Z. Chen, 2009, Leukemia.

MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma

A. Janin, S. Chen, C. Leboeuf, 2014, Leukemia.